ReviewPediatric nephrology (Berlin, Germany)2010
Medium-size-vessel vasculitis.
Review in Pediatric nephrology (Berlin, Germany), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 1 synthesis or guideline pooled it, 120 citations in OpenAlex.
- Post COVID-19 vaccination medium vessel vasculitis: a systematic review of case reports.Infection · 2024Pooled it
- Ruxolitinib combined with corticosteroids for the successful treatment of kawasaki disease-associated macrophage activation syndrome: a case report.Frontiers in pediatrics · 2026Article
- CT Coronary Angiogram in Diagnosing IgG4 of Coronary Arteries Presenting as Acute Coronary Syndrome: A Case Report with Review of Literature.The Indian journal of radiology & imaging · 2025Article
- Case Report: A case of cutaneous polyarteritis nodosa in a child following a streptococcal infection.Frontiers in pediatrics · 2025Article
- Childhood Vasculitis.Indian journal of pediatrics · 2024Review
- Overview of childhood vasculitis.Journal of rheumatic diseases · 2024Review
- [Evidence-based guidelines for the diagnosis and treatment of Kawasaki disease in children in China (2023)].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2023Article
- Recent Advances in Pediatric Vasculitis.Rheumatic diseases clinics of North America · 2021Review
- An Atypical Presentation of Polyarteritis Nodosa: Case Report and Review of the Literature.Cureus · 2021Article
- Primary care approach to Kawasaki disease.Singapore medical journal · 2021Article
- A large superior mesenteric artery aneurysm and ileal obstruction: a rare presentation of polyarteritis nodosa in an infant.Oxford medical case reports · 2019Article
- Testicular ischemia in deficiency of adenosine deaminase 2 (DADA2).Pediatric rheumatology online journal · 2019Article
- Kawasaki disease: guidelines of Italian Society of Pediatrics, part II - treatment of resistant forms and cardiovascular complications, follow-up, lifestyle and prevention of cardiovascular risks.Italian journal of pediatrics · 2018Review
- Kawasaki disease: guidelines of the Italian Society of Pediatrics, part I - definition, epidemiology, etiopathogenesis, clinical expression and management of the acute phase.Italian journal of pediatrics · 2018Review
- Vasculitis update: pathogenesis and biomarkers.Pediatric nephrology (Berlin, Germany) · 2018Review
- Childhood polyarteritis nodosa: diagnosis with non-invasive imaging techniques.Clinical rheumatology · 2017Article
- A Case of Polyarteritis Nodosa Presenting as Rapidly Progressing Intermittent Claudication of Right Leg.Case reports in medicine · 2017Article
- Kawasaki disease: a matter of innate immunity.Clinical and experimental immunology · 2016Review
- Impaired function of endothelial progenitor cells in children with primary systemic vasculitis.Arthritis research & therapy · 2015Article
- Elicitation of expert prior opinion: application to the MYPAN trial in childhood polyarteritis nodosa.PloS one · 2015Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Medium-size-artery vasculitides do occur in childhood and manifest, in the main, as polyarteritis nodosa (PAN), cutaneous PAN and Kawasaki disease. Of these, PAN is the most serious, with high morbidity and not inconsequential mortality rates. New classification criteria for PAN have been validated that will have value in epidemiological studies and clinical trials. Renal involvement is common and recent therapeutic advances may result in improved treatment options. Cutaneous PAN is a milder disease characterised by periodic exacerbations and often associated with streptococcal infection. There is controversy as to whether this is a separate entity or part of the systemic PAN spectrum. Kawasaki disease is an acute self-limiting systemic vasculitis, the second commonest vasculitis in childhood and the commonest cause of childhood-acquired heart disease. Renal manifestations occur and include tubulointerstitial nephritis and renal failure. An infectious trigger and a genetic predisposition seem likely. Intravenous immunoglobulin (IV-Ig) and aspirin are effective therapeutically, but in resistant cases, either steroid or infliximab have a role. Greater understanding of the pathogenetic mechanisms involved in these three types of vasculitis and better long-term follow-up data will lead to improved therapy and prediction of prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.